Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry.
about
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Improved survival and tumor co ...... from the PROCLAIMSM registry.
@en
Improved survival and tumor co ...... from the PROCLAIMSM registry.
@nl
type
label
Improved survival and tumor co ...... from the PROCLAIMSM registry.
@en
Improved survival and tumor co ...... from the PROCLAIMSM registry.
@nl
prefLabel
Improved survival and tumor co ...... from the PROCLAIMSM registry.
@en
Improved survival and tumor co ...... from the PROCLAIMSM registry.
@nl
P2093
P2860
P1476
Improved survival and tumor co ...... from the PROCLAIMSM registry.
@en
P2093
Brendan Curti
David F McDermott
Gregory A Daniels
Howard L Kaufman
Janice P Dutcher
Jatinder Singh
Joseph I Clark
Meenu Kaur
Michael A Morse
Michael K K Wong
P2860
P2888
P356
10.1186/S40425-017-0307-5
P577
2017-12-19T00:00:00Z
P6179
1099709320